{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:12:27Z","timestamp":1777475547856,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T00:00:00Z","timestamp":1573171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T00:00:00Z","timestamp":1573171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s12149-019-01417-x","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T15:53:36Z","timestamp":1573228416000},"page":"74-79","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Quantitative bone scan imaging using BSI and BUV: an approach to evaluate ARONJ early"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7924-3221","authenticated-orcid":false,"given":"Yayoi","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiyo","family":"Mitsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Horikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Hino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,8]]},"reference":[{"key":"1417_CR1","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al. American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw-2014 update. J Oral Maxillofac Surg. 2014;72:1938\u201356.","journal-title":"J Oral Maxillofac Surg"},{"key":"1417_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/RLU.0b013e3181feeb72","volume":"36","author":"T Van den Wyngaert","year":"2011","unstructured":"Van den Wyngaert T, Huizing MT, Fossion E, Vermorken JB. Prognostic value of bone scintigraphy in cancer patients with osteonecrosis of the jaw. Clin Nucl Med. 2011;36:17\u201320.","journal-title":"Clin Nucl Med"},{"key":"1417_CR3","first-page":"177","volume":"10","author":"A Zanglis","year":"2007","unstructured":"Zanglis A, Andreopoulos D, Dima M, Baltas G, Baziotis N. Jaw uptake of technetium-99 methylene diphosphonate in patients on biphosphonates: a word of caution. Hell J Nucl Med. 2007;10:177\u201380.","journal-title":"Hell J Nucl Med"},{"key":"1417_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2967\/jnumed.107.048785","volume":"50","author":"F Dore","year":"2009","unstructured":"Dore F, Filippi L, Biasotto M, Chiandussi S, Cavalli F, DiLenarda R. Bone scintigraphy and SPECT\/CT of bisphosphonate induced osteonecrosis of the jaw. J Nucl Med. 2009;50:30\u20135.","journal-title":"J Nucl Med"},{"key":"1417_CR5","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s13139-012-0144-x","volume":"46","author":"CM Hong","year":"2012","unstructured":"Hong CM, Ahn BC, Choi SY, Kim DH, Lee SW, Kwon TG, et al. Implications of three-phase bone scintigraphy for the diagnosis of bisphosphonate-related osteonecrosis of the jaw. Nucl Med Mol Imaging. 2012;46:162\u20138.","journal-title":"Nucl Med Mol Imaging"},{"issue":"3","key":"1417_CR6","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s10266-016-0279-9","volume":"105","author":"Y Ohbayashi","year":"2017","unstructured":"Ohbayashi Y, Nakai F, Iwasaki A, Ogawa T, Yamamoto Y, Nishiyama Y, et al. The utility of bone scintigraphy in the assessment of mandibular metabolism during long-term bisphosphonate administration. Odontology. 2017;105(3):382\u201390.","journal-title":"Odontology"},{"key":"1417_CR7","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/j.oooo.2012.09.006","volume":"115","author":"Y Ohbayashi","year":"2013","unstructured":"Ohbayashi Y, Miyake M, Sawai F, Minami Y, Iwasaki A, Matsui Y. Adjunct teriparatide therapy with monitoring of bone turnover markers and bone scintigraphy for bisphosphonate-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;115:e31\u20137.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol."},{"key":"1417_CR8","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.joms.2013.11.005","volume":"72","author":"O Ristow","year":"2014","unstructured":"Ristow O, Gerngross C, Schwaiger M, Hohlweg-Majert B, Kehl V, Jansen H, et al. Is bone turnover of jawbone and its possible over suppression by bisphosphonates of etiologic importance in pathogenesis of bisphosphonate-related osteonecrosis? J Oral Maxillofac Surg. 2014;72:903\u201310.","journal-title":"J Oral Maxillofac Surg"},{"key":"1417_CR9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00432-014-1588-4","volume":"140","author":"O Ristow","year":"2014","unstructured":"Ristow O, Gerngross C, Schwaiger M, Hohlweg-Majert B, Ristow M, Koerdt S, et al. Does regular zoledronic acid change the bone turnover of the jaw in men with metastatic prostate cancer: a possible clue to the pathogenesis of bisphosphonate related osteonecrosis of the jaw? J Cancer Res Clin Oncol. 2014;140:487\u201393.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1417_CR10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.bjoms.2014.01.021","volume":"52","author":"O Ristow","year":"2014","unstructured":"Ristow O, Gerngross C, Schwaiger M, Hohlweg-Majert B, Kehl V, Jansen H, et al. Effect of antiresorptive drugs on bony turnover in the jaw: denosumab compared with bisphosphonates. Br J Oral Maxillofac Surg. 2014;52:308\u201313.","journal-title":"Br J Oral Maxillofac Surg"},{"key":"1417_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/RLU.0000000000000296","volume":"39","author":"C Lapa","year":"2014","unstructured":"Lapa C, Linz C, Bluemel C, Mottok A, Mueller-Richter U, Kuebler A, et al. Three-phase bone scintigraphy for imaging osteoradionecrosis of the jaw. Clin Nucl Med. 2014;39:21\u20135.","journal-title":"Clin Nucl Med"},{"key":"1417_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s12149-016-1145-0","volume":"31","author":"S Watanabe","year":"2017","unstructured":"Watanabe S, Nakajima K, Mizokami A, Yaegashi H, Noguchi N, Kawashiri S, et al. Bone scan index of the jaw: a new approach for evaluating early-stage anti-resorptive agents-related osteonecrosis. Ann Nucl Med. 2017;31:201\u201310.","journal-title":"Ann Nucl Med"},{"key":"1417_CR13","first-page":"1401","volume":"38","author":"YE Erdi","year":"1997","unstructured":"Erdi YE, Humm JL, Lmbriaco M, Yeung H, Larson SM. Quantitative bone metastases analysis based on image segmentation. J Nucl Med. 1997;38:1401\u20136.","journal-title":"J Nucl Med"},{"key":"1417_CR14","doi-asserted-by":"publisher","first-page":"E628","DOI":"10.1111\/j.1464-410X.2012.11355.x","volume":"110","author":"Y Mitsui","year":"2012","unstructured":"Mitsui Y, Shiina H, Yamamoto Y, Haramoto M, Arichi N, Yasumoto H, et al. Prediction of survival benefit using an automated bone scan index in patients with castration-resistant prostate cancer. BJU Int. 2012;110:E628\u201334.","journal-title":"BJU Int"},{"key":"1417_CR15","first-page":"1765","volume":"4","author":"M Imbriaco","year":"1998","unstructured":"Imbriaco M, Larson SM, Yeung HW, Mawlawi OR, Erdi Y, Venkatraman ES, et al. A new parameter for measuring metastatic bone involvement by prostate cancer the bone scan index. Clin Cancer Res. 1998;4:1765\u201372.","journal-title":"Clin Cancer Res"},{"key":"1417_CR16","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1200\/JCO.2011.36.5791","volume":"30","author":"ER Dennis","year":"2012","unstructured":"Dennis ER, Jia X, Mezheritskiy IS, Stephenson RD, Schoder H, Fox JJ, et al. Bone scan index: a quantitative treatment response biomarker for castration-resistant metastatic prostate cancer. J Clin Oncol. 2012;30:519\u201324.","journal-title":"J Clin Oncol"},{"key":"1417_CR17","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/MNM.0b013e3283503ebf","volume":"33","author":"MS Brown","year":"2012","unstructured":"Brown MS, Chu GH, Kim HJ, Allen-Auerbach M, Poon C, Bridges J, et al. Computer-aided quantitative bone scan assessment of prostate cancer treatment response. Nucl Med Commun. 2012;33:384\u201394.","journal-title":"Nucl Med Commun"},{"key":"1417_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/sj.bjc.6600715","volume":"88","author":"M Noguchi","year":"2003","unstructured":"Noguchi M, Kikuchi H, Ishibashi M, Noda S. Percentage of the positive area of bone metastasis is an independent predictor of disease death in advanced prostate cancer. Br J Cancer. 2003;88:195\u2013201.","journal-title":"Br J Cancer"},{"key":"1417_CR19","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.clinimag.2015.06.009","volume":"39","author":"RF Jiang","year":"2015","unstructured":"Jiang RF, Zhang L, Cheng B, Huang Z, Li DL, Wang MM, et al. Increased uptake of Tc-99\u00a0m-methylene diphosphonate in the jaw. Clin Imaging. 2015;39:1068\u201372.","journal-title":"Clin Imaging"},{"key":"1417_CR20","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/00006231-200403000-00015","volume":"25","author":"JA Arias","year":"2004","unstructured":"Arias JA, Pardo C, Olmos A, Cuadrado ML, Ruibal A. Dental diseases and radionuclide imaging of the jaws. Nucl Med Commun. 2004;25:305\u201310.","journal-title":"Nucl Med Commun"},{"key":"1417_CR21","first-page":"845","volume":"19","author":"DE Tow","year":"1978","unstructured":"Tow DE, Garcia DA, Jansons D, Sullivan TM, Niederman R. Bone scan in dental diseases. J Nucl Med. 1978;19:845\u20137.","journal-title":"J Nucl Med"},{"key":"1417_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/annonc\/mdn630","volume":"20","author":"T Van den Wyngaert","year":"2009","unstructured":"Van den Wyngaert T, Claeys T, Huizing MT, Vermorken JB, Fossion E. Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome. Ann Oncol. 2009;20:331\u20136.","journal-title":"Ann Oncol"},{"key":"1417_CR23","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1200\/JCO.2008.16.9300","volume":"20","author":"A Badros","year":"2008","unstructured":"Badros A, Terpos E, Katodritou E, Goloubeva O, Kastritis E, Verrou E, et al. Natural history of osteonecrosis of the jaw in patients with multiple myeloma. J Clin Oncol. 2008;20:5904\u20139.","journal-title":"J Clin Oncol"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-019-01417-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-019-01417-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-019-01417-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:44:57Z","timestamp":1604709897000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-019-01417-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,8]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["1417"],"URL":"https:\/\/doi.org\/10.1007\/s12149-019-01417-x","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,8]]},"assertion":[{"value":"1 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No potential conflicts of interest were disclosed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}